Rhabdomyosarcoma (RMS) is the most common soft tissue tumor of childhood. Genitourinary
(GU) RMS was initially treated with radical removal of reproductive organs, but there
has been a shift toward organ-sparing surgeries with chemotherapy (chemo) and radiation
(RT) as per the Intergroup Rhabdomyosarcoma Study Group (IRSG). Due to the rarity
of GU RMS, treatment is still variable. The goal of our multicenter study is to describe
treatment and outcomes in GU RMS and to discern if there is an association between
patient or disease characteristics and proposed treatment.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Pediatric and Adolescent GynecologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
